Arca
Skip to content

SLC18A2: Synaptic vesicular amine transporter

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Electrogenic antiporter that exchanges one cationic monoamine with two intravesicular protons across the membrane of secretory and synaptic vesicles.

  • Drugs that act on it: 8
  • With a US drug page: 6
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
BenzphetamineApprovedSynaptic vesicular amine transporter inhibitorInhibitor—
DeserpidineApprovedSynaptic vesicular amine transporter inhibitorInhibitor—
RescinnamineApprovedSynaptic vesicular amine transporter inhibitorInhibitor—
ReserpineApprovedSynaptic vesicular amine transporter inhibitorInhibitorWithdrawn
TetrabenazineApprovedSynaptic vesicular amine transporter inhibitorInhibitorBoxed warning
ValbenazineApprovedSynaptic vesicular amine transporter inhibitorInhibitorBoxed warning
Dextroamphetamine—Synaptic vesicular amine transporter inhibitorInhibitorBoxed warning
Lisdexamfetamine—Synaptic vesicular amine transporter inhibitorInhibitorBoxed warning

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Brain dopamine-serotonin vesicular transport disease
0.71
Parkinsonism-dystonia, infantile
0.67
Movement disorder
0.58
Choreatic disease
0.57
Hypertensive disorder
0.56
Alzheimer disease
0.51
Obesity disorder
0.51
Narcolepsy-cataplexy syndrome
0.50
Drug dependence
0.46
Arteriosclerosis
0.46

Drugs and mechanisms are from ChEMBL CHEMBL1893 (CC BY-SA 3.0). Gene name, function (UniProt Q05940, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.